Ernexa Therapeutics (ERNAW) Times Interest Earned (2015 - 2023)

Ernexa Therapeutics (ERNAW) has 17 years of Times Interest Earned data on file, last reported at -$143.33 in Q1 2026.

• Quarterly Times Interest Earned fell 4100.24% year-over-year to -$143.33 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$312.26 (down 16681.74% YoY) and the FY2025 annual result came in at -$0.36, up 40.82% from the prior year.
• Times Interest Earned retreated to -$143.33 in Q1 2026, from -$3.19 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $4.06 in Q4 2022 to a low of -$143.33 in Q1 2026.
• A 5-year average of -$19.52 and a median of -$3.93 in 2022 frame the typical range for Times Interest Earned.
• Annual changes were most pronounced in 2022 — Times Interest Earned soared 110.11% — and 2026, when it slumped 4100.24%.
• Tracing ERNAW's Times Interest Earned over 5 years: stood at $4.06 in 2022, then sank by 2352.44% to -$91.51 in 2023, then soared by 100.29% to $0.27 in 2024, then slumped by 1294.17% to -$3.19 in 2025, then slumped by 4394.9% to -$143.33 in 2026.
• The last three Times Interest Earned figures came in at -$143.33 (Q1 2026), -$3.19 (Q3 2025), and -$3.74 (Q2 2025), per Business Quant data.